Sept 2011: UK study on new CMV treatment gets funding

     
At the moment the main treatment available for congenital CMV  is Ganciclovir. However it is an invasive treatment for a newborn baby (it is administered via intraveinous drip), and in some cases it can cause adverse effects. Also, Ganciclovir treatment must be started before a baby is 4 weeks old, leaving a very small window  of opportunity to combat the possible effects of CMV, especially if it is not diagnosed immediately at birth. [singlepic id=59 w=250 float=left]A new study has just been awarded funding to test a less invasive oral antiviral called Valganciclovir. The study will  test 6 weeks of valgancyclovir treatment in infants aged 1-18 months old, significantly increasing the potential window for treating congenital CMV. Please email info@cmvaction.org.uk if you are interested in finding out more. &;

Tags: 

  • news
     

Our Stories

April 2014 Hi everyone, meet chocolate faced Darcie. She is my beautiful 20 month old daughter. I was diagnosed CMV positive when I was 6 months pregnant. It is thought that I caught it... Read more
April 1982 I guess I had a pretty typical childhood with some exceptions.  Here is what my mother has to say: “Kristen was born 10:58am on April 5th, 1982 weighing 6lbs 1oz after... Read more

Latest Events

Reg. charity no: 1171773